1. Home
  2. BWXT vs PCVX Comparison

BWXT vs PCVX Comparison

Compare BWXT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

HOLD

Current Price

$150.54

Market Cap

16.5B

Sector

N/A

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$59.23

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWXT
PCVX
Founded
1867
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
7.0B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
BWXT
PCVX
Price
$150.54
$59.23
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$209.70
$88.25
AVG Volume (30 Days)
1.0M
927.4K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
0.52%
N/A
EPS Growth
16.61
N/A
EPS
0.99
N/A
Revenue
$1,687,738,000.00
N/A
Revenue This Year
$20.47
N/A
Revenue Next Year
$9.50
N/A
P/E Ratio
$158.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$147.74
$30.81
52 Week High
$241.82
$65.00

Technical Indicators

Market Signals
Indicator
BWXT
PCVX
Relative Strength Index (RSI) 40.68 47.74
Support Level $147.74 $58.51
Resistance Level $179.92 $63.39
Average True Range (ATR) 5.30 2.10
MACD 0.67 -0.39
Stochastic Oscillator 32.47 10.69

Price Performance

Historical Comparison
BWXT
PCVX

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: